ADMIRUS has considerable global expertise in navigating both pre-clinical and clinical development and understand the requirements for entry-into-man studies, single and escalating dose Phase 1 studies and more advanced phase II/III efficacy/safety studies. Navigating the regulatory terrain is a cor...See more
Headquarter Australia |
Year founded 2022 (2 years) |
Funding status Private |
Company type SME |
Director
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
- | hidden.item | hidden.item | hidden.item | |||
Director | hidden.item | hidden.item | hidden.item |